Constipation - FunctionalNCT07483229
A Clinical Study on Warm Needling Moxibustion at Tianshu and Guanyuan Acupoints
A study testing Warm Needling and Electroacupuncture in people with Constipation - Functional, run by The First Affiliated Hospital of Henan University of Traditional Chinese Medicine at 1 site in China.
Trial summary
This study aims to compare the effectiveness of two different acupuncture techniques for treating a specific type of chronic constipation, known in Traditional Chinese Medicine as "Yang deficiency type" chronic functional constipation. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Constipation - Functional
- What is being tested?
- Warm Needling and Electroacupuncture
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteChina
- Study dates
- 1 Aug 2022to 30 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 18 to 65 years, either sex
- Meeting the Rome IV diagnostic criteria for functional constipation
- Meeting the Traditional Chinese Medicine diagnostic criteria for Yang deficiency type constipation
- No other treatments received before inclusion
- Exclusion of organic digestive system lesions confirmed by colonoscopy or other appropriate examinations
- Voluntary participation with signed informed consent
Who cannot join
- Not meeting the inclusion criteria
- Pregnant or lactating women
- Serious cardiovascular or cerebrovascular diseases
- Inability to receive abdominal acupuncture due to skin diseases or other local conditions
- Participation in other clinical trials within the past 3 months
Trial locations and contacts
1 site in 1 country.
China1 site
the First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, 450000,
About this study
This study aims to compare the effectiveness of two different acupuncture techniques for treating a specific type of chronic constipation, known in Traditional Chinese Medicine as "Yang deficiency type" chronic functional constipation.
Chronic functional constipation is a common condition characterized by difficult or infrequent bowel movements. The "Yang deficiency" pattern is believed to be caused by a lack of functional energy (Qi) and warmth in the body, leading to sluggish bowel motility.
Read more
This study will enroll 60 eligible participants who will be randomly assigned to one of two groups:
Experimental Group: Participants will receive "warm needling" therapy. This involves inserting acupuncture needles at specific points (Tianshu and Guanyuan) and then burning a small moxa stick on the needle handle to generate heat.
Control Group: Participants will receive electroacupuncture at the same acupoints. This involves attaching the needles to a device that delivers a mild electric current.
Both groups will receive treatment every other day, three times a week, for a total of four weeks. We will assess their constipation symptoms, anxiety and depression levels, and quality of life using standardized questionnaires immediately after the 4-week treatment and again 6 months later. The goal is to see which method provides better relief, both in the short term and long term.
Read the detailed description
Background and Rationale Chronic functional constipation (FC) is a highly prevalent disorder that significantly diminishes quality of life and is frequently associated with psychological comorbidities such as anxiety and depression. Within the framework of Traditional Chinese Medicine (TCM), a prominent subtype is "Yang deficiency type" FC. Its pathophysiology is understood as a deficiency of Yang Qi, resulting in slowed metabolism and weakened motility of the large intestine. The acupoints Tianshu (ST25), the Front-Mu point of the Large Intestine, and Guanyuan (CV4), the Front-Mu point of the Small Intestine and a crucial point for nourishing Yuan Qi, are classically combined to warm Yang and regulate intestinal function. This trial investigates whether the combined thermal and stimulatory effects of warm needling at these points offer superior and more sustained clinical benefits compared to electroacupuncture alone.
Study Design and Methodology This is a single-center, parallel-group, superiority randomized controlled trial with a 1:1 allocation ratio, conducted at the First Affiliated Hospital of Henan University of Chinese Medicine. A total of 60 participants diagnosed with Yang deficiency type chronic FC will be randomized into either an experimental group (warm needling) or a control group (electroacupuncture).
Intervention Details Experimental Group (Warm Needling): After standard disinfection, single-use sterile stainless steel needles (0.25×40mm) will be inserted perpendicularly at Tianshu (ST25) and Guanyuan (CV4) to achieve deqi (the characteristic needling sensation). Subsequently, a prepared moxa stick (approx. 2cm in diameter, 3cm in length) will be attached to the handle of each needle and ignited. The heat is conducted down the needle to the deeper tissues. Needles will be retained for 30 minutes with careful monitoring to prevent burns.
Control Group (Electroacupuncture): Needle insertion and deqi technique will be identical to the experimental group. Needle handles will then be connected to an electroacupuncture device (Hwato SDZ-V series) delivering a dense-sparse wave (2/15 Hz) at an intensity sufficient to produce mild, non-painful muscle twitching. Needles will be retained for 30 minutes.
Both groups will receive treatment every other day, three times weekly, for a total course of four weeks.
Therapeutic Rationale Tianshu (ST25) is strategically selected for its direct regulatory effect on large intestine function. Guanyuan (CV4) is chosen for its powerful action in warming and tonifying Yang Qi. The warm needling technique synergistically combines the meridian-regulating effect of acupuncture with the deep, penetrating warmth of moxibustion. This is hypothesized to enhance local circulation, modulate neuroendocrine pathways involved in the brain-gut axis, and provide a more potent Yang-tonifying effect than electroacupuncture alone, potentially leading to more durable improvements in bowel function.
Follow-up and Outcome Assessment To evaluate the sustainability of the treatment effect, all participants will undergo a follow-up assessment six months after the completion of the 4-week treatment course. No study-related interventions will be provided during this period. The primary outcome is the change from baseline in the Constipation Severity Score (CSS) at week 4 and month 6. Secondary outcomes include changes in TCM syndrome score, Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), and Patient Assessment of Constipation Quality of Life (PAC-QOL) scale. Outcome assessors and statisticians will be blinded to group allocation. Analysis will be conducted on an intention-to-treat basis.
Significance This study aims to provide rigorous clinical evidence on the efficacy of warm needling for a well-defined TCM condition. By including a 6-month follow-up, it will offer valuable insights into the durability of the therapeutic response, informing clinical practice and guiding future research on non-pharmacological interventions for chronic functional constipation.
- Conditions
- Constipation - Functional
- Being tested
- Warm Needling, Electroacupuncture
- Keywords
- Yang Deficiency, Warm Needling, Tianshu Acupoint, Guanyuan Acupoint, Traditional Chinese Medicine, Randomized Controlled Trial
- Medical subject headings
- Yang Deficiency
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Warm NeedlingDevice
Also called Warming Acupuncture
Warm Needling: After routine disinfection with 75% alcohol, disposable sterile stainless steel acupuncture needles (0.25×40 mm) are inserted perpendicularly at Tianshu (ST25) to a depth of approximately 25 mm and at Guanyuan (CV4) to approximately 20 mm. After achieving deqi (local soreness, distension, or radiation to ipsilateral abdomen or groin), a moxa stick (diameter 2 cm, length 3 cm) is ignited and attached to the needle handle with the lit end facing upward. Needles are retained for 30 minutes per session, with care taken to avoid skin burns. Treatment is administered every other day, three times weekly, for a total of four weeks.
ElectroacupunctureDevice
Also called Electrical Acupuncture
Electroacupuncture:After routine disinfection with 75% alcohol, disposable sterile stainless steel acupuncture needles (0.25×40 mm) are inserted perpendicularly at Tianshu (ST25) to a depth of approximately 25 mm and at Guanyuan (CV4) to approximately 20 mm. After achieving deqi (local soreness, distension, or radiation to ipsilateral abdomen or groin), a balanced tonifying and reducing technique is used. The needle handles are connected to an electroacupuncture device (Hwato SDZ-V series electronic needle therapy instrument) with a dense-sparse wave (2/15 Hz) at an intensity sufficient to produce mild muscle twitching. Needles are retained for 30 minutes per session. Treatment is administered every other day, three times weekly, for a total of four weeks.
| Study group | Role | What they receive |
|---|---|---|
| Warm Needling at Tianshu and Guanyuan | Experimental | Participants receive warm needling therapy at Tianshu (ST25) and Guanyuan (CV4) acupoints. After achieving deqi (needling sensation) with standard acupuncture needles (0.25×40mm), a moxa stick (2cm diameter, 3cm length) is ignited and attached to the needle handle, providing combined thermal and acupoint stimulation for 30 minutes per session. Treatment is administered every other day, three times weekly, for a total of four weeks. Receives: Device: Warm Needling |
| Electroacupuncture at Tianshu and Guanyuan | Active comparator | Participants receive electroacupuncture at Tianshu (ST25) and Guanyuan (CV4) acupoints. After achieving deqi with standard acupuncture needles (0.25×40mm), needle handles are connected to an electroacupuncture device (Hwato SDZ-V series) delivering a dense-sparse wave (2/15 Hz) at an intensity sufficient to produce mild muscle twitching. Needles are retained for 30 minutes per session. Treatment is administered every other day, three times weekly, for a total of four weeks. Receives: Device: Electroacupuncture |
What is being measured
The primary outcome is the main question the study is designed to answer.
Constipation Severity Score (CSS)
Change from baseline in Constipation Severity Score (CSS) at week 4 and month 6. CSS (Cleveland Constipation Scoring System) assesses constipation severity; higher scores indicate greater severity.
Measured: Change from baseline in Constipation Severity Score (CSS) at week 4 and month 6.
Secondary outcomes (5)
TCM syndrome score
A TCM syndrome scoring scale was developed based on the 'Consensus Opinion on the Diagnosis and Treatment of Functional Constipation Using Integrated Traditional Chinese and Western Medicine (2017)'. Primary symptoms were scored 0, 2, 4, 6; secondary symptoms 0, 1, 2, 3.
Measured: Change from baseline in TCM syndrome score at week 4 and month 6.
Self-Rating Anxiety Scale (SAS) score
Change from baseline in Self-Rating Anxiety Scale (SAS) score at week 4 and month 6. Higher scores indicate more severe anxiety.
Measured: Change from baseline in Self-Rating Anxiety Scale (SAS) score at week 4 and month 6.
Self-Rating Depression Scale (SDS) score
Change from baseline in Self-Rating Depression Scale (SDS) score at week 4 and month 6. Higher scores indicate more severe depression.
Measured: Change from baseline in Self-Rating Depression Scale (SDS) score at week 4 and month 6
Patient Assessment of Constipation Quality of Life (PAC-QOL) scale
Change from baseline in Patient Assessment of Constipation Quality of Life (PAC-QOL) scale at week 4 and month 6. Higher scores indicate worse quality of life.
Measured: Change from baseline in Patient Assessment of Constipation Quality of Life (PAC-QOL) scale at week 4 and month 6
Clinical efficacy
Clinical efficacy at week 4, categorized as cured, significantly effective, effective, or ineffective according to the consensus. Total effective rate = (cured+significantly effective+effective)/total×100%.
Measured: Clinical efficacy at week 4
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2026
- Study start1 Aug 2022
- Primary completion30 Oct 2025
- Study completion30 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Constipation - FunctionalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Parallel-group, superiority randomized controlled trial with 1:1 allocation. Participants are randomized to receive either warm needling or electroacupuncture at Tianshu (ST25) and Guanyuan (CV4). Both groups follow the same treatment schedule: every other day, three times weekly for four weeks. Outcome assessors and statisticians are blinded to group allocation; participants and acupuncturists are not blinded due to the nature of the interventions.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yongkang An, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07483229
- Sponsor's protocol ID
- 2022HL-428-01
- Other IDs
- 2024ZXZX1102, 2022JDZX010
- Status last verified
- Mar 2026
- First submitted
- 12 Mar 2026
- Last updated
- 19 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Study on Warm Needling Moxibustion at Tianshu and Guanyuan Acupoints
- ClinicalTrials.gov ID
- NCT07483229
- Acronym / sponsor ID
- 2022HL-428-01
- Conditions
- Constipation - Functional
- Keywords
- Yang Deficiency, Warm Needling, Tianshu Acupoint, Guanyuan Acupoint, Traditional Chinese Medicine, Randomized Controlled Trial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- The First Affiliated Hospital of Henan University of Traditional Chinese MedicineUniversity, hospital or other
- Study start
- 1 Aug 2022 (actual)
- Primary completion
- 30 Oct 2025 (actual)
- Study completion
- 30 Oct 2025 (actual)
- First posted
- 19 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to compare the effectiveness of two different acupuncture techniques for treating a specific type of chronic constipation, known in Traditional Chinese Medicine as "Yang deficiency type" chronic functional constipation.
Chronic functional constipation is a common condition characterized by difficult or infrequent bowel movements. The "Yang deficiency" pattern is believed to be caused by a lack of functional energy (Qi) and warmth in the body, leading to sluggish bowel motility.
This study will enroll 60 eligible participants who will be randomly assigned to one of two groups:
Experimental Group: Participants will receive "warm needling" therapy. This involves inserting acupuncture needles at specific points (Tianshu and Guanyuan) and then burning a small moxa stick on the needle handle to generate heat.
Control Group: Participants will receive electroacupuncture at the same acupoints. This involves attaching the needles to a device that delivers a mild electric current.
Both groups will receive treatment every other day, three times a week, for a total of four weeks. We will assess their constipation symptoms, anxiety and depression levels, and quality of life using standardized questionnaires immediately after the 4-week treatment and again 6 months later. The goal is to see which method provides better relief, both in the short term and long term.
Detailed description
Background and Rationale Chronic functional constipation (FC) is a highly prevalent disorder that significantly diminishes quality of life and is frequently associated with psychological comorbidities such as anxiety and depression. Within the framework of Traditional Chinese Medicine (TCM), a prominent subtype is "Yang deficiency type" FC. Its pathophysiology is understood as a deficiency of Yang Qi, resulting in slowed metabolism and weakened motility of the large intestine. The acupoints Tianshu (ST25), the Front-Mu point of the Large Intestine, and Guanyuan (CV4), the Front-Mu point of the Small Intestine and a crucial point for nourishing Yuan Qi, are classically combined to warm Yang and regulate intestinal function. This trial investigates whether the combined thermal and stimulatory effects of warm needling at these points offer superior and more sustained clinical benefits compared to electroacupuncture alone.
Study Design and Methodology This is a single-center, parallel-group, superiority randomized controlled trial with a 1:1 allocation ratio, conducted at the First Affiliated Hospital of Henan University of Chinese Medicine. A total of 60 participants diagnosed with Yang deficiency type chronic FC will be randomized into either an experimental group (warm needling) or a control group (electroacupuncture).
Intervention Details Experimental Group (Warm Needling): After standard disinfection, single-use sterile stainless steel needles (0.25×40mm) will be inserted perpendicularly at Tianshu (ST25) and Guanyuan (CV4) to achieve deqi (the characteristic needling sensation). Subsequently, a prepared moxa stick (approx. 2cm in diameter, 3cm in length) will be attached to the handle of each needle and ignited. The heat is conducted down the needle to the deeper tissues. Needles will be retained for 30 minutes with careful monitoring to prevent burns.
Control Group (Electroacupuncture): Needle insertion and deqi technique will be identical to the experimental group. Needle handles will then be connected to an electroacupuncture device (Hwato SDZ-V series) delivering a dense-sparse wave (2/15 Hz) at an intensity sufficient to produce mild, non-painful muscle twitching. Needles will be retained for 30 minutes.
Both groups will receive treatment every other day, three times weekly, for a total course of four weeks.
Therapeutic Rationale Tianshu (ST25) is strategically selected for its direct regulatory effect on large intestine function. Guanyuan (CV4) is chosen for its powerful action in warming and tonifying Yang Qi. The warm needling technique synergistically combines the meridian-regulating effect of acupuncture with the deep, penetrating warmth of moxibustion. This is hypothesized to enhance local circulation, modulate neuroendocrine pathways involved in the brain-gut axis, and provide a more potent Yang-tonifying effect than electroacupuncture alone, potentially leading to more durable improvements in bowel function.
Follow-up and Outcome Assessment To evaluate the sustainability of the treatment effect, all participants will undergo a follow-up assessment six months after the completion of the 4-week treatment course. No study-related interventions will be provided during this period. The primary outcome is the change from baseline in the Constipation Severity Score (CSS) at week 4 and month 6. Secondary outcomes include changes in TCM syndrome score, Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), and Patient Assessment of Constipation Quality of Life (PAC-QOL) scale. Outcome assessors and statisticians will be blinded to group allocation. Analysis will be conducted on an intention-to-treat basis.
Significance This study aims to provide rigorous clinical evidence on the efficacy of warm needling for a well-defined TCM condition. By including a 6-month follow-up, it will offer valuable insights into the durability of the therapeutic response, informing clinical practice and guiding future research on non-pharmacological interventions for chronic functional constipation.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Parallel-group, superiority randomized controlled trial with 1:1 allocation. Participants are randomized to receive either warm needling or electroacupuncture at Tianshu (ST25) and Guanyuan (CV4). Both groups follow the same treatment schedule: every other day, three times weekly for four weeks. Outcome assessors and statisticians are blinded to group allocation; participants and acupuncturists are not blinded due to the nature of the interventions.
| Arm | Type | Receives |
|---|---|---|
| Warm Needling at Tianshu and Guanyuan | Experimental | Device: Warm NeedlingParticipants receive warm needling therapy at Tianshu (ST25) and Guanyuan (CV4) acupoints. After achieving deqi (needling sensation) with standard acupuncture needles (0.25×40mm), a moxa stick (2cm diameter, 3cm length) is ignited and attached to the needle handle, providing combined thermal and acupoint stimulation for 30 minutes per session. Treatment is administered every other day, three times weekly, for a total of four weeks. |
| Electroacupuncture at Tianshu and Guanyuan | Active comparator | Device: ElectroacupunctureParticipants receive electroacupuncture at Tianshu (ST25) and Guanyuan (CV4) acupoints. After achieving deqi with standard acupuncture needles (0.25×40mm), needle handles are connected to an electroacupuncture device (Hwato SDZ-V series) delivering a dense-sparse wave (2/15 Hz) at an intensity sufficient to produce mild muscle twitching. Needles are retained for 30 minutes per session. Treatment is administered every other day, three times weekly, for a total of four weeks. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age 18 to 65 years, either sex
- Meeting the Rome IV diagnostic criteria for functional constipation
- Meeting the Traditional Chinese Medicine diagnostic criteria for Yang deficiency type constipation
- No other treatments received before inclusion
- Exclusion of organic digestive system lesions confirmed by colonoscopy or other appropriate examinations
Key exclusion criteria (5 listed)
- Not meeting the inclusion criteria
- Pregnant or lactating women
- Serious cardiovascular or cerebrovascular diseases
- Inability to receive abdominal acupuncture due to skin diseases or other local conditions
- Participation in other clinical trials within the past 3 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Warm NeedlingAlso: Warming AcupunctureWarm Needling: After routine disinfection with 75% alcohol, disposable sterile stainless steel acupuncture needles (0.25×40 mm) are inserted perpendicularly at Tianshu (ST25) to a depth of approximately 25 mm and at Guanyuan (CV4) to approximately 20 mm. After achieving deqi (local soreness, distension, or radiation to ipsilateral abdomen or groin), a moxa stick (diameter 2 cm, length 3 cm) is ignited and attached to the needle handle with the lit end facing upward. Needles are retained for 30 minutes per session, with care taken to avoid skin burns. Treatment is administered every other day, three times weekly, for a total of four weeks. | Device | Warm Needling at Tianshu and Guanyuan |
| ElectroacupunctureAlso: Electrical AcupunctureElectroacupuncture:After routine disinfection with 75% alcohol, disposable sterile stainless steel acupuncture needles (0.25×40 mm) are inserted perpendicularly at Tianshu (ST25) to a depth of approximately 25 mm and at Guanyuan (CV4) to approximately 20 mm. After achieving deqi (local soreness, distension, or radiation to ipsilateral abdomen or groin), a balanced tonifying and reducing technique is used. The needle handles are connected to an electroacupuncture device (Hwato SDZ-V series electronic needle therapy instrument) with a dense-sparse wave (2/15 Hz) at an intensity sufficient to produce mild muscle twitching. Needles are retained for 30 minutes per session. Treatment is administered every other day, three times weekly, for a total of four weeks. | Device | Electroacupuncture at Tianshu and Guanyuan |
Primary outcome
Constipation Severity Score (CSS)
Time frame: Change from baseline in Constipation Severity Score (CSS) at week 4 and month 6.
Change from baseline in Constipation Severity Score (CSS) at week 4 and month 6. CSS (Cleveland Constipation Scoring System) assesses constipation severity; higher scores indicate greater severity.
5 secondary outcomes
TCM syndrome score
Time frame: Change from baseline in TCM syndrome score at week 4 and month 6.
Self-Rating Anxiety Scale (SAS) score
Time frame: Change from baseline in Self-Rating Anxiety Scale (SAS) score at week 4 and month 6.
Self-Rating Depression Scale (SDS) score
Time frame: Change from baseline in Self-Rating Depression Scale (SDS) score at week 4 and month 6
Patient Assessment of Constipation Quality of Life (PAC-QOL) scale
Time frame: Change from baseline in Patient Assessment of Constipation Quality of Life (PAC-QOL) scale at week 4 and month 6
Clinical efficacy
Time frame: Clinical efficacy at week 4
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Constipation - Functional
RecruitingPhase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Irritable Bowel Syndrome, Constipation
Active, not recruitingPhase 2
This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC
Functional Constipation (FC)
Not yet recruitingPhase 3
Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders
Bloating, Rifaximin
Recruiting
Effects of Connective Tissue Massage Plus Biofeedback for Dyssynergic Defecation
Dyssynergic Defecation
RecruitingObservational study
Relationship Between Interoception and Postural Control in Constipation-Predominant Irritable Bowel Syndrome
Constipation, Irritable Bowel Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Warm Needling and Electroacupuncture in people with Constipation - Functional, run by The First Affiliated Hospital of Henan University of Traditional Chinese Medicine at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Constipation Severity Score (CSS) (time frame: Change from baseline in Constipation Severity Score (CSS) at week 4 and month 6.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2026.